Personalized melanoma vaccine shows promise in cutting cancer recurrence nearly in half
LEXINGTON, Ky. (ABC36 NEWS NOW) – A major breakthrough in cancer treatment could change the way high-risk melanoma is fought, with early results showing a new personalized vaccine may cut the risk of the cancer returning by nearly half. According to research released by pharmaceutical companies Moderna and Merck, the experimental vaccine uses mRNA technology — the same platform made…